Christopher Ford

Company: Seres Therapeutics

Job title: VP

Seminars:

Panel Discussion: Using AI-Enhanced Phenotyping to Provide Novel Understanding of IBD Heterogeneity 9:30 am

To what extent will AI reshape the classification of IBD subtypes? What insights does classify IBD subtypes provide into disease heterogeneity? Delving into AI-enhanced phenotyping for tailoring bespoke treatment options Read more

day: AI/Machine Learning Pre-Conference Focus Day